【多选题】You work as an application developer at Contoso.com. You use Microsoft .NET Framework 3.5 and Microsoft ADO.NET to develop an application that will connect to the Microsoft SQL Server 2005 database. Y...
【多选题】How does the European Medicines Agency (EMA) define gene therapy medicinal products (GTMPs)?
A.
EMA defines "gene therapy medicinal products (GTMPs) generally consist of a vector or delivery formulation/system containing a genetic construct engineered to express a specific transgene ('therapeutic sequence') for the regulation, repair, replacement, addition or deletion of a genetic sequence. The active substance is the nucleic acid sequence(s), or genetically modified microorganism(s), virus(es) or cells.
B.
EMA defines that a gene therapy medicinal product is a biological medicinal product.
C.
EMA defines that a gene therapy medicinal product fulfills the following two characteristics: (a) it contains an active substance which contains or consists of a recombinant nucleic acid used in or administered to human beings with a view to regulating, repairing, replacing, adding or deleting a genetic sequence; (b) its therapeutic, prophylactic or diagnostic effect relates directly to the recombinant nucleic acid sequence it contains, or to the product of genetic expression of this sequence.
D.
Gene therapy medicinal products shall not include vaccines against infectious diseases.